Epidemiology of Type 2 Diabetes -- Pathogenesis of Type 2 Diabetes Mellitus -- Metabolic Mechanisms of Muscle Insulin Resistance -- Fat Metabolism in Insulin Resistance and Type 2 Diabetes -- Detection and Diagnosis of Type 2 Diabetes -- Therapies for Delay or Prevention of Type 2 Diabetes -- Postprandial Hyperglycemia -- Medical Nutrition Therapy in Type 2 Diabetes -- Exercise as an Effective Treatment for Type 2 Diabetes -- Type 2 Diabetes Mellitus: An Evidence-Based Approach to Practical Management -- The Transition from Oral Agents to Combination Insulin/Oral Therapy -- Intensive Insulin Therapy in T2DM -- Hypoglycemia in Type 2 Diabetes -- Type 2 Diabetes and Concomitant Illness -- Adherence to Practice Guidelines for People with Diabetes Mellitus -- Treatment of Hypertension in Type 2 Diabetes -- Lipoproteins in Diabetes: Risk and Opportunity -- Management of Coronary Artery Disease in Type 2 Diabetes Mellitus -- Peripheral Vascular Disease Stroke inType2Diabetes -- Obesity and Its Treatment in Type 2 Diabetes -- The Liver in Type 2 Diabetes Mellitus -- Developing Criteria for Defining Type 2 Diabetes in Pregnancy -- Metabolic Complications of Polycystic Ovary Syndrome -- Erectile Dysfunction in Diabetes -- Sexual Dysfunction in Women with Type 2 Diabetes -- Depression in Type 2 Diabetes -- Atypical Forms of Type 2 Diabetes -- Diabetes Mellitus Type 2 and Stress: Pathophysiology and Treatment -- Pharmacologic Factors Affecting Glycemic Control -- Influencing Self-Management: From Compliance to Collaboration.

As the global epidemic of diabetes continues to expand, the prevalence of type 2 diabetes is predicted to double in the next 20 years. Type 2 Diabetes Mellitus: An Evidence-Based Approach to Practical Management addresses this problem by expertly synthesizing the currently available evidence regarding specific issues in diabetes care. Written by an interdisciplinary team of scientists and medical professionals and comprising a wealth of information in a single resource, the book integrates the best evidence for the full range of clinical issues surrounding the evaluation and treatment of type 2 diabetes, including comorbid conditions such as hypertension, hyperlipidemia, and vascular disease. To quantify the strength of evidence supporting current practices, each chapter highlights related conditions, including fatty liver disease, pregnancy, and polycystic ovarian syndrome, and also addresses barriers to treatment, including stress, depression, and patient motivation.